WallStreetZenWallStreetZen

NASDAQ: IXHL
Incannex Healthcare Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their IXHL stock forecasts and price targets.

Forecast return on equity

Is IXHL forecast to generate an efficient return?

Company
21.09%
Industry
34.92%
Market
150.38%
IXHL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IXHL forecast to generate an efficient return on assets?

Company
20.64%
Industry
15.03%
IXHL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IXHL earnings per share forecast

What is IXHL's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.89
Avg 2 year Forecast
$1.30

IXHL revenue forecast

What is IXHL's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$63.0M

IXHL vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
IXHL$3.25N/AN/A
SCYX$0.86$3.00+249.24%Strong Buy
INCR$0.79N/AN/A
ZYBT$0.78N/AN/A
TLPH$0.80N/AN/A
View Top Pharmaceutical Stocks

Incannex Healthcare Stock Forecast FAQ

What is IXHL's earnings growth forecast for 2026-2027?

(NASDAQ: IXHL) Incannex Healthcare's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 46.44%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,669.49%.

Incannex Healthcare's earnings in 2026 is -$48,499,000.On average, 3 Wall Street analysts forecast IXHL's earnings for 2026 to be -$22,573,553, with the lowest IXHL earnings forecast at -$21,687,285, and the highest IXHL earnings forecast at -$23,236,463.

In 2027, IXHL is forecast to generate $15,478,633 in earnings, with the lowest earnings forecast at $14,871,862 and the highest earnings forecast at $15,933,711.

If you're new to stock investing, here's how to buy Incannex Healthcare stock.

What is IXHL's revenue growth forecast for 2026-2027?

(NASDAQ: IXHL) Incannex Healthcare's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.25%.

Incannex Healthcare's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast IXHL's revenue for 2026 to be $0, with the lowest IXHL revenue forecast at $0, and the highest IXHL revenue forecast at $0.

In 2027, IXHL is forecast to generate $752,396,039 in revenue, with the lowest revenue forecast at $722,893,590 and the highest revenue forecast at $774,528,847.

What is IXHL's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: IXHL) forecast ROA is 20.64%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 15.03%.

What is IXHL's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: IXHL) Incannex Healthcare's current Earnings Per Share (EPS) is -$22.50. On average, analysts forecast that IXHL's EPS will be -$1.89 for 2026, with the lowest EPS forecast at -$1.82, and the highest EPS forecast at -$1.95. In 2027, IXHL's EPS is forecast to hit $1.30 (min: $1.25, max: $1.33).

What is IXHL's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: IXHL) forecast ROE is 21.09%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.